{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T13:14:31Z","timestamp":1784294071645,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":51,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2021-KH113146"],"award-info":[{"award-number":["RS-2021-KH113146"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023443","name":"Commercializations Promotion Agency for R and D Outcomes","doi-asserted-by":"publisher","award":["2710086164"],"award-info":[{"award-number":["2710086164"]}],"id":[{"id":"10.13039\/501100023443","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-48310-y","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T05:27:21Z","timestamp":1776058041000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Positive prognostic implications of SPHK1 expression in patients with papillary thyroid carcinoma undergoing radioactive iodine therapy"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0429-4218","authenticated-orcid":false,"given":"Kyung Won","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6271-2105","authenticated-orcid":false,"given":"Ja Seong","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0995-6482","authenticated-orcid":false,"given":"Dong-Jun","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6843-3708","authenticated-orcid":false,"given":"Chan Kwon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"issue":"1","key":"48310_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","volume":"33","author":"ZW Baloch","year":"2022","unstructured":"Baloch, Z. W. et al. Overview of the 2022 WHO classification of thyroid neoplasms. Endocr. Pathol. 33(1), 27\u201363. https:\/\/doi.org\/10.1007\/s12022-022-09707-3 (2022).","journal-title":"Endocr. Pathol."},{"issue":"8","key":"48310_CR2","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1177\/10507256251363120","volume":"35","author":"MD Ringel","year":"2025","unstructured":"Ringel, M. D. et al. 2025 American thyroid association management guidelines for adult patients with differentiated thyroid cancer. Thyroid 35(8), 841\u2013985. https:\/\/doi.org\/10.1177\/10507256251363120 (2025).","journal-title":"Thyroid"},{"issue":"1","key":"48310_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen, B. R. et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1), 1\u2013133. https:\/\/doi.org\/10.1089\/thy.2015.0020 (2016).","journal-title":"Thyroid"},{"issue":"3","key":"48310_CR4","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3803\/EnM.2025.2465","volume":"40","author":"S Moon","year":"2025","unstructured":"Moon, S. et al. The initial risk stratification system for differentiated thyroid cancer: Key updates in the 2024 Korean thyroid association guideline. Endocrinol. Metab. (Seoul). 40(3), 357\u2013384. https:\/\/doi.org\/10.3803\/EnM.2025.2465 (2025).","journal-title":"Endocrinol. Metab. (Seoul)"},{"issue":"1","key":"48310_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s12022-025-09858-z","volume":"36","author":"F Haq","year":"2025","unstructured":"Haq, F., Bychkov, A., Mete, O., Jeon, S. & Jung, C. K. Identification of specific biomarkers for anaplastic thyroid carcinoma through spatial transcriptomic and immunohistochemical profiling. Endocr. Pathol. 36(1), 14. https:\/\/doi.org\/10.1007\/s12022-025-09858-z (2025).","journal-title":"Endocr. Pathol."},{"issue":"2","key":"48310_CR6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/bab.1922","volume":"68","author":"SG Khoei","year":"2020","unstructured":"Khoei, S. G., Sadeghi, H., Samadi, P., Najafi, R. & Saidijam, M. Relationship between Sphk1\/S1P and microRNAs in human cancers. Biotechnol. Appl. Biochem. 68(2), 279\u2013287. https:\/\/doi.org\/10.1002\/bab.1922 (2020).","journal-title":"Biotechnol. Appl. Biochem."},{"issue":"4","key":"48310_CR7","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00432-016-2315-0","volume":"143","author":"W Liang","year":"2017","unstructured":"Liang, W. et al. Comprehensive gene and microRNA expression profiling reveals a role for miRNAs in the oncogenic roles of SphK1 in papillary thyroid cancer. J. Cancer Res. Clin. Oncol. 143(4), 601\u2013611. https:\/\/doi.org\/10.1007\/s00432-016-2315-0 (2017).","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"1","key":"48310_CR8","doi-asserted-by":"publisher","first-page":"18239","DOI":"10.1038\/s41598-022-20976-0","volume":"12","author":"P Bhadwal","year":"2022","unstructured":"Bhadwal, P., Randhawa, V., Vaiphei, K., Dahiya, D. & Agnihotri, N. Clinical relevance of CERK and SPHK1 in breast cancer and their association with metastasis and drug resistance. Sci. Rep. 12(1), 18239. https:\/\/doi.org\/10.1038\/s41598-022-20976-0 (2022).","journal-title":"Sci. Rep."},{"issue":"2","key":"48310_CR9","doi-asserted-by":"publisher","first-page":"663","DOI":"10.21873\/anticanres.13161","volume":"39","author":"GE Bae","year":"2019","unstructured":"Bae, G. E. et al. Increased sphingosine kinase 1 expression predicts distant metastasis and poor outcome in patients with colorectal cancer. Anticancer Res. 39(2), 663\u2013670. https:\/\/doi.org\/10.21873\/anticanres.13161 (2019).","journal-title":"Anticancer Res."},{"issue":"2","key":"48310_CR10","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3892\/ol.2019.10447","volume":"18","author":"M Gachechiladze","year":"2019","unstructured":"Gachechiladze, M. et al. Sphingosine kinase-1 predicts overall survival outcomes in non-small cell lung cancer patients treated with carboplatin and navelbine. Oncol. Lett. 18(2), 1259\u20131266. https:\/\/doi.org\/10.3892\/ol.2019.10447 (2019).","journal-title":"Oncol. Lett."},{"key":"48310_CR11","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3389\/fonc.2016.00218","volume":"6","author":"YI Rodriguez","year":"2016","unstructured":"Rodriguez, Y. I. et al. Sphingosine-1 phosphate: a new modulator of immune plasticity in the tumor microenvironment. Front. Oncol. 6, 218. https:\/\/doi.org\/10.3389\/fonc.2016.00218 (2016).","journal-title":"Front. Oncol."},{"issue":"6","key":"48310_CR12","doi-asserted-by":"publisher","first-page":"5007","DOI":"10.3892\/etm.2018.6054","volume":"15","author":"Z Zhao","year":"2018","unstructured":"Zhao, Z., Ma, J., Hu, B., Zhang, Y. & Wang, S. SPHK1 promotes metastasis of thyroid carcinoma through activation of the S1P\/S1PR3\/Notch signaling pathway. Exp. Ther. Med. 15(6), 5007\u20135016. https:\/\/doi.org\/10.3892\/etm.2018.6054 (2018).","journal-title":"Exp. Ther. Med."},{"issue":"10","key":"48310_CR13","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.3390\/cancers12103042","volume":"12","author":"YM Jeong","year":"2020","unstructured":"Jeong, Y. M. et al. CD73 overexpression promotes progression and recurrence of papillary thyroid carcinoma. Cancers (Basel) 12(10), 3042. https:\/\/doi.org\/10.3390\/cancers12103042 (2020).","journal-title":"Cancers (Basel)"},{"issue":"3","key":"48310_CR14","doi-asserted-by":"publisher","first-page":"e0174737","DOI":"10.1371\/journal.pone.0174737","volume":"12","author":"Y Kim","year":"2017","unstructured":"Kim, Y. et al. Prognostic implication of histological features associated with EHD2 expression in papillary thyroid carcinoma. PLoS One 12(3), e0174737. https:\/\/doi.org\/10.1371\/journal.pone.0174737 (2017).","journal-title":"PLoS One"},{"key":"48310_CR15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.humpath.2017.10.015","volume":"71","author":"A Bychkov","year":"2018","unstructured":"Bychkov, A. & Jung, C. K. Aberrant expression of CD20 in thyroid cancer and its clinicopathologic significance. Hum. Pathol. 71, 74\u201383. https:\/\/doi.org\/10.1016\/j.humpath.2017.10.015 (2018).","journal-title":"Hum. Pathol."},{"issue":"3","key":"48310_CR16","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3390\/cancers12030596","volume":"12","author":"S Choden","year":"2020","unstructured":"Choden, S., Keelawat, S., Jung, C. K. & Bychkov, A. VE1 immunohistochemistry improves the limit of genotyping for detecting BRAF(V600E) mutation in papillary thyroid cancer. Cancers (Basel) 12(3), 596. https:\/\/doi.org\/10.3390\/cancers12030596 (2020).","journal-title":"Cancers (Basel)"},{"issue":"6","key":"48310_CR17","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.3390\/cancers12061413","volume":"12","author":"EJ Oh","year":"2020","unstructured":"Oh, E. J. et al. Prognostic implications of CD10 and CD15 expression in papillary thyroid carcinoma. Cancers (Basel) 12(6), 1413. https:\/\/doi.org\/10.3390\/cancers12061413 (2020).","journal-title":"Cancers (Basel)"},{"issue":"18","key":"48310_CR18","doi-asserted-by":"publisher","first-page":"7199","DOI":"10.7150\/thno.102390","volume":"14","author":"Q Fang","year":"2024","unstructured":"Fang, Q. et al. SPHK1 promotes HNSCC immune evasion by regulating the MMP1-PD-L1 axis. Theranostics 14(18), 7199\u20137218. https:\/\/doi.org\/10.7150\/thno.102390 (2024).","journal-title":"Theranostics"},{"issue":"7","key":"48310_CR19","doi-asserted-by":"publisher","first-page":"4550","DOI":"10.1097\/JS9.0000000000002506","volume":"111","author":"Y Miao","year":"2025","unstructured":"Miao, Y. et al. Potential of SPHK1 as a prognostic marker and therapeutic target in colorectal cancer: insights from bioinformatics and experimental analysis. Int. J. Surg. 111(7), 4550\u20134575. https:\/\/doi.org\/10.1097\/JS9.0000000000002506 (2025).","journal-title":"Int. J. Surg."},{"issue":"5","key":"48310_CR20","doi-asserted-by":"publisher","first-page":"5374","DOI":"10.3892\/ol.2019.10910","volume":"18","author":"J Li","year":"2019","unstructured":"Li, J. et al. Upregulation of sphingosine kinase 1 is associated with recurrence and poor prognosis in papillary thyroid carcinoma. Oncol. Lett. 18(5), 5374\u20135382. https:\/\/doi.org\/10.3892\/ol.2019.10910 (2019).","journal-title":"Oncol. Lett."},{"issue":"1","key":"48310_CR21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s12022-025-09849-0","volume":"36","author":"V Condello","year":"2025","unstructured":"Condello, V., Marchettini, C., Ihre-Lundgren, C., Nilsson, J. N. & Juhlin, C. C. Comprehensive gene expression analysis in papillary thyroid carcinoma reveals a transcriptional profile associated with reduced radioiodine avidity. Endocr. Pathol. 36(1), 4. https:\/\/doi.org\/10.1007\/s12022-025-09849-0 (2025).","journal-title":"Endocr. Pathol."},{"key":"48310_CR22","doi-asserted-by":"publisher","DOI":"10.1530\/etj-24-0319","author":"T Hiromasa","year":"2025","unstructured":"Hiromasa, T., Wakabayashi, H., Watanabe, S., Yamase, T. & Kinuya, S. Enhancing radioactive iodine (RAI) incorporation in RAI-refractory differentiated thyroid cancer: current insights. Eur. Thyroid J. https:\/\/doi.org\/10.1530\/etj-24-0319 (2025).","journal-title":"Eur. Thyroid J."},{"issue":"6","key":"48310_CR23","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1210\/er.2019-00007","volume":"40","author":"ME Cabanillas","year":"2019","unstructured":"Cabanillas, M. E., Ryder, M. & Jimenez, C. Targeted therapy for advanced thyroid cancer: Kinase inhibitors and beyond. Endocr. Rev. 40(6), 1573\u20131604. https:\/\/doi.org\/10.1210\/er.2019-00007 (2019).","journal-title":"Endocr. Rev."},{"issue":"7","key":"48310_CR24","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.3390\/ijms23074010","volume":"23","author":"N Ueda","year":"2022","unstructured":"Ueda, N. A rheostat of ceramide and sphingosine-1-phosphate as a determinant of oxidative stress-mediated kidney injury. Int. J. Mol. Sci. 23(7), 4010 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"48310_CR25","doi-asserted-by":"publisher","first-page":"4481","DOI":"10.3390\/ijms21124481","volume":"21","author":"M Francis","year":"2020","unstructured":"Francis, M., Abou Daher, A., Azzam, P., Mroueh, M. & Zeidan, Y. Modulation of DNA damage response by sphingolipid signaling: An interplay that shapes cell fate. Int. J. Mol. Sci. 21, 4481. https:\/\/doi.org\/10.3390\/ijms21124481 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"48310_CR26","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1146\/annurev-immunol-081519-083952","volume":"38","author":"AAL Baeyens","year":"2020","unstructured":"Baeyens, A. A. L. & Schwab, S. R. Finding a way out: S1P signaling and immune cell migration. Annu. Rev. Immunol. 38, 759\u2013784. https:\/\/doi.org\/10.1146\/annurev-immunol-081519-083952 (2020).","journal-title":"Annu. Rev. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48310-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48310-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48310-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:02:58Z","timestamp":1780444978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48310-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48310"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48310-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"2 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki and was approved by the Institutional Review Board of Seoul St. Mary\u2019s Hospital (KC16SISI0104), College of Medicine, The Catholic University of Korea. Informed consent was waived by the board. The biospecimens and data used for this study were provided by the Biobank of Seoul St. Mary\u2019s Hospital, The Catholic University of Korea, a member of the Korea Biobank Network (KBN4_A01).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was waived by the institutional review board because of the retrospective nature of this study, which used anonymous clinical data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors approved for the publication of this paper.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"17100"}}